Gabriel Ling
Board Member
Starling Oncology, Inc. (STLN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gabriel Ling
Gabriel Ling is recorded as Board Member at Starling Oncology, Inc. (STLN). Starling Oncology, Inc. reported in an 8-K filed December 1, 2025 that Gabriel Ling resigned as Board of Directors, effective December 1, 2025. Starling Oncology, Inc. reported in an 8-K filed September 22, 2022 that Gabriel Ling was appointed Board, effective September 21, 2022.
“On November 26, 2025, Gabriel Ling resigned from the Board of Directors of The Oncology Institute, Inc. (the "Company"), effective on December 1, 2025.”
“the Board appointed Mr. Mark Pacala and Mr. Gabriel Ling to the Board, effective immediately, each to serve until the Company's 2023 Annual Meeting of Stockholders and until his successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-21–present
-
Start not stated–2025-12-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Starling Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Virnich CEO, COO, Board Member
- Anne McGeorge Chairman
- Brad Hively Chairman
- Robert Carter CFO, Chief Accounting Officer
- Dr. Matt Miller COO
- Jeremy N. Castle COO
- Mark Huppelsheuser General Counsel
- Dr. Gregory Sorensen Board Member
- Dr. Jennifer Carter Board Member
- Dr. Mohit Kaushal Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.